Relationship Between a Frailty-Related Phenotype and Progressive Deterioration of the Immune System in HIV-Infected Men

被引:134
作者
Desquilbet, Loic [1 ]
Margolick, Joseph B. [2 ]
Fried, Linda P. [3 ,4 ]
Phair, John P. [5 ,6 ]
Jamieson, Beth D. [7 ]
Holloway, Warcy [8 ]
Jacobson, Lisa P. [1 ]
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
[3] Johns Hopkins Sch Med, Div Geriatr Med & Gerontol, Baltimore, MD USA
[4] Johns Hopkins Sch Med, Ctr Aging & Hlth, Baltimore, MD USA
[5] Northwestern Univ, Howard Brown Hlth Ctr, Chicago, IL 60611 USA
[6] Northwestern Univ, Dept Med, Chicago, IL 60611 USA
[7] Univ Calif Los Angeles, UCLA Med Ctr, Geffen Sch Med, Dept Med, Los Angeles, CA USA
[8] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA
关键词
aging; CD4 T-cell count; frailty; highly active antiretroviral therapy; HIV; prospective population-based cohort; HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS-FACTOR-ALPHA; MULTICENTER AIDS COHORT; HEALTH SURVEY SF-36; ANTIRETROVIRAL THERAPY; OXIDATIVE STRESS; REPLICATIVE SENESCENCE; LYMPHOCYTE SUBSETS; WASTING SYNDROME; OLDER-ADULTS;
D O I
10.1097/QAI.0b013e3181945eb0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Context: Immunological similarities have been noted between HIV-infected individuals and older HIV-negative adults. immunologic alterations with aging have been noted in frailty in older adults, a clinical syndrome of high risk for mortality and other adverse outcomes. Using a frailty-related phenotype (FRP), we investigated in the Multicenter AIDS Cohort Study whether progressive deterioration of the immune system among HIV-positive individuals independently predicts onset of FRP. Methods: FRP was evaluated semiannually in 1046 HIV-infected men from 1994 to 2005. CD4 T-cell Count and plasma viral load were evaluated as predictors of FRP by logistic regression. (generalized estimating equations), adjusting for age, ethnicity, educational level, AIDS status, and treatment era [pre-highly active antiretroviral therapy (HAART) (1994-1995) and HAART (1996-1999 and 2000-2005)]. Results: Adjusted prevalences of FRP remained low for CD4 T-cell counts > 400 cells per cubic millimeter and increased exponentially and significantly for lower counts. Results were unaffected by treatment era. After 1996, CD4 T-cell count, but not plasma viral load, was independently associated with FRP. Conclusions: CD4 T-cell count predicted the development of a FRP among HIV-infected men, independent of HAART use. This suggests that compromise of the immune system in HTV-infected individuals contributes to the systemic physiologic dysfunction of frailty.
引用
收藏
页码:299 / 306
页数:8
相关论文
共 86 条
[1]
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[2]
[Anonymous], SCI AGING KNOWLEDGE, DOI DOI 10.1126/SAGEKE.2005.3T.PE24
[3]
Immune activation and inflammation in HIV-I infection: causes and consequences [J].
Appay, V. ;
Sauce, D. .
JOURNAL OF PATHOLOGY, 2008, 214 (02) :231-241
[4]
Premature ageing of the immune system: the cause of AIDS? [J].
Appay, V ;
Rowland-Jones, SL .
TRENDS IN IMMUNOLOGY, 2002, 23 (12) :580-585
[5]
Accelerated immune senescence and HIV-1 infection [J].
Appay, Victor ;
Almeida, Jorge R. ;
Sauce, Delphine ;
Autran, Brigitte ;
Papagno, Laura .
EXPERIMENTAL GERONTOLOGY, 2007, 42 (05) :432-437
[6]
SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND SOLUBLE TNF RECEPTORS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - CORRELATIONS TO CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL PARAMETERS [J].
AUKRUST, P ;
LIABAKK, NB ;
MULLER, F ;
LIEN, E ;
ESPEVIK, T ;
FROLAND, SS .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :420-424
[7]
Phenotype of frailty: Characterization in the women's health and aging studies [J].
Bandeen-Roche, K ;
Xue, QL ;
Ferrucci, L ;
Walston, J ;
Guralnik, JM ;
Chaves, P ;
Zeger, SL ;
Fried, LP .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2006, 61 (03) :262-266
[8]
BIRX DL, 1990, BLOOD, V76, P2303
[9]
BREEN EC, 1990, J IMMUNOL, V144, P480
[10]
Bruunsgaard H, 2002, EUR CYTOKINE NETW, V13, P389